Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blood Coagulation Disorders: full-pipeline trial registry
1 of 7 indexed Blood Coagulation Disorders trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 1 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Blood Coagulation Disorders: 7 US clinical trials tracked, 1 recruiting.
Blood Coagulation Disorders is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Instituto Bioclon S.A. de C.V., running 1 of these trials.
Enrollment posture brief
Registry condition blood-coagulation-disorders
OPEN 1 | RECR 14% | LATE 1 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adverse Drug Events (14% recruiting · 7 trials)
Blood Coagulation Disorders lists 1 open slots (14% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blood Coagulation Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blood Coagulation Disorders is recruiting below its size-band peers.
1 of 7 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Blood Coagulation Disorders trials is spread across many organizations.
Instituto Bioclon S.A. de C.V. accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Blood Coagulation Disorders trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Blood Coagulation Disorders splits between interventional and observational designs.
3 interventional and 4 observational studies make up this index (42.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
University of Chicago
NCT01280825
Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy
CSL Behring
NCT00708435
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
University of Illinois at Chicago
NCT02776566
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
George Washington University
NCT00522002
Thrombin Generation in Neonates
Emory University
NCT00165906
A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,
Instituto Bioclon S.A. de C.V.
NCT00868309
Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles
National Human Genome Research Institute (NHGRI)
NCT00086476
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Blood Coagulation Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blood Coagulation Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blood Coagulation Disorders page
7 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Blood Coagulation Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Instituto Bioclon S.A. de C.V. sponsors the most Blood Coagulation Disorders trials on record, review their full trial history before evaluating a specific study. See Instituto Bioclon S.A. de C.V.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Coagulation Disorders condition card totals 7 registered trials; most-linked intervention Patient Self-Monitoring vs Anticoagulation Clinic; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.